Filing Flows › AbbVie (ABBV) › Free cash flow
AbbVie (ABBV) free cash flow by quarter
AbbVie's free cash flow was $7.3B in Q3 2026 (third quarter 2026), +135% from Q2 2026. Over the last 7 quarters it ranged from $1.4B (Q1 2025) to $7.3B (Q3 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $7.3B | +135% | +10% |
| Q2 2026 | $3.1B | -13% | -36% |
| Q1 2026 | $3.6B | -27% | +155% |
| Q4 2025 | $4.9B | -26% | — |
| Q3 2025 | $6.6B | +36% | — |
| Q2 2025 | $4.9B | +249% | — |
| Q1 2025 | $1.4B | — | — |
Q3 2026 at a glance
AbbVie, Q3 2026: revenue $17.4B (+10% year over year), operating margin 36.0%, net earnings $4.2B, operating cash flow $7.6B. The chart follows the revenue to costs, profit and cash.
Questions
What is AbbVie's free cash flow?
AbbVie's free cash flow was $7.3B in Q3 2026 (third quarter 2026), +135% from Q2 2026.
How has AbbVie's free cash flow changed?
Over the last 7 quarters it ranged from $1.4B (Q1 2025) to $7.3B (Q3 2026).